Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis.
Alzheimer’s Research & Therapy; doi.org/10.1186/s13195-020-00728-w.
Resveratrol-mediated cleavage of amyloid β1-42 peptide; potential relevance to Alzheimer’s disease.
Neurobiology of Aging; doi.org/10.1016/j.neurobiolaging.2020.04.012.
Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: A pilot study.
bioRxiv; doi: doi.org/10.1101/2020.05.16.093559..
Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies.
Scientific Reports; doi.org/10.1038/s41598-020-77210-y.
A curcumin-based NIR fluorescence probe for detection of amyloid-beta (Aβ) plaques in Alzheimer's disease
Dyes and Pigments; https://doi.org/10.1016/j.dyepig.2018.12.003.
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound.
Future Medicinal Chemistry; DOI: 10.4155/fmc-2018-0473.
Mercury and Alzheimer’s Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization
Biomolecules; https://doi.org/10.3390/biom10010044.
Highly sensitive quantification of Alzheimer's disease biomarkers by aptamer-assisted amplification
Theranostics.; DOI: 10.7150/thno.29232.
Toxicity of Amyloid-β Peptides Varies Depending on Differentiation Route of SH-SY5Y Cells.
J Alzheimers Dis.; DOI: 10.3233/JAD-190705.
Aldosterone, STX and amyloid-β1-42 peptides modulate GPER (GPR30) signalling in an embryonic mouse hippocampal cell line (mHippoE-18).
Molecular and Cellular Endocrinology; https://doi.org/10.1016/j.mce.2019.110537.